Company
Gemphire Therapeutics
- Business model
- B2B
Record updated 28 September 2026
About
Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing gemcabene for the treatment of dyslipidemia.
Company
Record updated 28 September 2026
Gemphire Therapeutics is a clinical-stage biopharmaceutical company focused on developing and commercializing gemcabene for the treatment of dyslipidemia.
A first look at Gemphire Therapeutics’s connections in the VC Catalog database. Sign in with Google to open the interactive map.
Investor VC firms in this preview
VC firm names are a sample from VC Catalog’s database and may be incomplete. A database connection is not a guarantee of an introduction.